Fusion proteins comprising an anti-CD40 antibody and cancer antigens
US-11806390-B2 · Nov 7, 2023 · US
This patent family groups 3 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 42729026 |
| Family type | — |
| Earliest priority | Mar 10, 2009 |
| First filing country | US |
| Member publications | 3 |
| Countries | US |
| Representative publication | US11806390B2 — Fusion proteins comprising an anti-CD40 antibody and cancer antigens |
Best representative member for this family based on priority and filing country.
US11806390B2 — Fusion proteins comprising an anti-CD40 antibody and cancer antigens (published Nov 7, 2023)
Related publications in this family.
US-11806390-B2 · Nov 7, 2023 · US
US-2021308242-A1 · Oct 7, 2021 · US
US-10980869-B2 · Apr 20, 2021 · US